Improvements in histologic, symptomatic, and endoscopic aspects of eosinophilic esophagitis are maintained, or continue to improve, with long-term dupilumab treatment, regardless of prior esophageal dilation

Category Primary study
JournalSwiss Medical Weekly
Year 2024
This article has no abstract
Epistemonikos ID: 1dda92649d4620ce6b5683492c321711abb6f0dd
First added on: Feb 19, 2025